BB-204

N/A

Report date: 2024/06/21 17:07:14

Base Information

Drug NameBB-204
Drug Alias NameBB-204
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor-associated antigen modulatorsAnti-HER2
TargetsTumor-associated antigenReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBright Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesBright Biologics LLC
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A